Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

Related Articles by Review for PubMed (Select 23539505)

1.

Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis.

Calcagno C, Ramachandran S, Millon A, Robson PM, Mani V, Fayad Z.

Curr Cardiovasc Imaging Rep. 2013 Feb 1;6(1):11-24. Epub 2012 Oct 14.

2.

Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesis.

Calcagno C, Mani V, Ramachandran S, Fayad ZA.

Angiogenesis. 2010 Jun;13(2):87-99. doi: 10.1007/s10456-010-9172-2. Epub 2010 Jun 6. Review.

PMID:
20526859
3.

MR imaging of the arterial vessel wall: molecular imaging from bench to bedside.

Makowski MR, Botnar RM.

Radiology. 2013 Oct;269(1):34-51. doi: 10.1148/radiol.13102336. Review.

PMID:
24062561
4.

Gadofosveset: MS 325, MS 32520, Vasovist, ZK 236018.

[No authors listed]

Drugs R D. 2004;5(6):339-42. Review.

PMID:
15563237
5.

Histological validation of iron-oxide and gadolinium based MRI contrast agents in experimental atherosclerosis: the do's and don't's.

den Adel B, Bovens SM, te Boekhorst B, Strijkers GJ, Poelmann RE, van der Weerd L, Pasterkamp G.

Atherosclerosis. 2012 Dec;225(2):274-80. doi: 10.1016/j.atherosclerosis.2012.07.028. Epub 2012 Jul 27. Review.

PMID:
22882907
6.

Tissue-specific MR contrast agents.

Weinmann HJ, Ebert W, Misselwitz B, Schmitt-Willich H.

Eur J Radiol. 2003 Apr;46(1):33-44. Review.

PMID:
12648800
7.

Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.

Aime S, Castelli DD, Crich SG, Gianolio E, Terreno E.

Acc Chem Res. 2009 Jul 21;42(7):822-31. doi: 10.1021/ar800192p. Review.

PMID:
19534516
8.

Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes.

Briley-Saebo KC, Mulder WJ, Mani V, Hyafil F, Amirbekian V, Aguinaldo JG, Fisher EA, Fayad ZA.

J Magn Reson Imaging. 2007 Sep;26(3):460-79. Review.

PMID:
17729343
9.

Gadolinium-based contrast agents for magnetic resonance cancer imaging.

Zhou Z, Lu ZR.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013 Jan-Feb;5(1):1-18. doi: 10.1002/wnan.1198. Epub 2012 Oct 9. Review.

10.

MRI contrast agents: current status and future perspectives.

Strijkers GJ, Mulder WJ, van Tilborg GA, Nicolay K.

Anticancer Agents Med Chem. 2007 May;7(3):291-305. Review.

PMID:
17504156
11.

Determination of gadolinium-based MRI contrast agents in biological and environmental samples: a review.

Telgmann L, Sperling M, Karst U.

Anal Chim Acta. 2013 Feb 18;764:1-16. doi: 10.1016/j.aca.2012.12.007. Epub 2012 Dec 13. Review.

PMID:
23374209
12.
13.
14.

Imaging of atherosclerosis: magnetic resonance imaging.

Corti R, Fuster V.

Eur Heart J. 2011 Jul;32(14):1709-19b. doi: 10.1093/eurheartj/ehr068. Epub 2011 Apr 19. Review.

15.

Plaque imaging and characterization using magnetic resonance imaging: towards molecular assessment.

Sirol M, Fuster V, Fayad ZA.

Curr Mol Med. 2006 Aug;6(5):541-8. Review.

PMID:
16918374
16.

Characterization and molecular detection of atherothrombosis by magnetic resonance--potential tools for individual risk assessment and diagnostics.

Ala-Korpela M, Sipola P, Kaski K.

Ann Med. 2006;38(5):322-36. Review. Erratum in: Ann Med. 2006;38(7):528.

PMID:
16938802
17.

[Diagnosis of renal artery stenosis with magnetic resonance angiography and stenosis quantification].

Marchand B, Hernandez-Hoyos M, Orkisz M, Douek P.

J Mal Vasc. 2000 Dec;25(5):312-320. Review. French.

PMID:
11148391
18.
19.

Recent developments and new perspectives on imaging of atherosclerotic plaque: role of anatomical, cellular and molecular MRI Part I and II.

te Boekhorst BC, Cramer MJ, Pasterkamp G, van Echteld CJ, Doevendans PA.

Int J Cardiovasc Imaging. 2010 Apr;26(4):433-45. doi: 10.1007/s10554-009-9565-8. Epub 2010 Jan 29. Review.

PMID:
20112134
20.

Molecular magnetic resonance imaging with targeted contrast agents.

Artemov D.

J Cell Biochem. 2003 Oct 15;90(3):518-24. Review.

PMID:
14523986
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk